Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative reviewopen access
- Authors
- Oh, Soohyun; Paik, Haerin; Park, Soo Jin; Lee, Eun Ji; Kim, Hee Seung
- Issue Date
- Mar-2021
- Publisher
- AME PUBLISHING COMPANY
- Keywords
- Pressurized; intraperitoneal (IP); aerosol; chemotherapy; ovarian; fallopian; peritoneal; cancer
- Citation
- GLAND SURGERY, v.10, no.3, pp 1244 - 1251
- Pages
- 8
- Journal Title
- GLAND SURGERY
- Volume
- 10
- Number
- 3
- Start Page
- 1244
- End Page
- 1251
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74155
- DOI
- 10.21037/gs-2019-ursoc-12
- ISSN
- 2227-684X
2227-8575
- Abstract
- For recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis (PC), it is challenging to resect tumors completely or to get complete remission by intravenous (IV) chemotherapy, and many patients show the resistance to various chemotherapeutic agents for IV chemotherapy ultimately. As an alternative, pressurized intraperitoneal aerosol chemotherapy ( PIPAC) has been introduced for treating the disease, which delivers chemotherapeutic agents as an aerosol form while maintaining high intraperitoneal (IP) pressure. Based on preclinical studies, PIPAC showed better penetration depth and distribution of drugs into the peritoneum in comparison to conventional IP chemotherapy. Tumor regression on histology and peritoneal carcinomatosis index (PCI) has also been shown in relevant studies. In addition, most of the PIPAC procedures were completed successfully with acceptable toxicity due to the use of a low dose of chemotherapeutic agents. For considering these advantages of PIPAC, we review the current status of PIPAC for treating recurrent ovarian, fallopian or primary peritoneal cancer through literature review.
- Files in This Item
-
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74155)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.